Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now has funded $25,084,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 163 grants at over 100 hospitals in 29 countries.




Telethon Kids Institute - $49,512

Amount
$49,512.00
Date
August 2019

Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.

Grant Information

Oncoceutics ONC201 - Phase II - $83,333

Amount
$83,333.00
Date
May 2019

Expansion of the ONC201 Compassionate Use.

Grant Information
Learn More

Funding of PBTCF 2019: PBTC-058 - $25,000

Amount
$25,000.00
Date
January 2019

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Grant Information

Sydney Children’s Hospital - $175,089

Amount
$175,089.00
Date
November 2018

Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma

Grant Information

Cincinnati Children's Hospital - $540,742

Amount
$540,742.00
Date
November 2018

Expansion of the International DIPG Registry.

Grant Information

Bambino Gesú Children's Hospital - $99,382

Amount
$99,382.00
Date
November 2018

Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.

Grant Information

Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000

Amount
$35,000.00
Date
November 2018

Credentialing an Improved DIPG Mouse Model.

Grant Information

Oncoceutics ONC201 - $83,333

Amount
$83,333.00
Date
October 2018

Expansion of the ONC201 Compassionate Use.

Grant Information
Learn More

The Institute of Cancer Research - $100,000

Amount
$100,000.00
Date
October 2018

Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children

Grant Information

The Institute of Cancer Research - $106,647

Amount
$106,647.00
Date
October 2018

A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.

Grant Information

Johns Hopkins Children's Center - $50,000

Amount
$50,000.00
Date
July 2018

Using Zebrafish to Accelerate DIPG Drug Development.

Grant Information

Funding of PBTCF 2018: PBTC-058 - $16,800

Amount
$16,800.00
Date
January 2018

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Grant Information

The Campbell Family Institute for Cancer Research - $100,000

Amount
$100,000.00
Date
October 2017

Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets

Grant Information

Institute of Cancer Research - $102,432

Amount
$102,432.00
Date
October 2017

Combinational strategies alongside ACVR1 inhibition in DIPG

Grant Information

The Regents of the University of California - $70,000

Amount
$70,000.00
Date
October 2017

An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy

Grant Information